Maryland
|
001-14494
|
33-0724736
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
10 North Park Place, Suite 201, Morristown, NJ
|
07960
|
|
(Address of principal executive offices)
|
(Zip Code)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No. | Description | |
99.1 |
Press release by the Company dated January 20, 2015.
|
PERNIX THERAPEUTICS HOLDINGS, INC.
|
|||
Dated: January 27, 2015
|
By:
|
/s/ SANJAY S. PATEL
|
|
Sanjay S. Patel
|
|||
Chief Financial Officer
|
|||
(Principal Financial Officer)
|
Exhibit No. | Description | |
99.1 |
Press release by the Company dated January 20, 2015.
|